On April 30, 2020, the Centers for Medicare & Medicaid
Services ("CMS") issued its Second Interim Final Rule in
response to the COVID-19 pandemic, which includes additional
regulatory waivers and rule changes. After reviewing comments to
its First Interim Final Rule
published on April 6, 2020, CMS is now attempting to provide even
more flexibility to health care providers in furnishing services to
combat the spread of COVID-19. To do so, CMS focuses on increasing
access to hospital services and laboratory and diagnostic testing
in settings that will allow individuals to receive the care without
jeopardizing their health or the health of those providing the
services.
The Second Interim Final Rule is effective as of today, May 8,
2020. Because it is an interim final rule, comments may be received
within 60 days (by July 7, 2020).